Literature DB >> 17611356

Vulnerability of feline T-lymphocytes to charged particles.

Takehiko Kakizaki1, Nobuyuki Hamada, Tetsuya Sakashita, Seiichi Wada, Takamitsu Hara, Tomoo Funayama, Tsutomu Hohdatsu, Masahiro Natsuhori, Tadashi Sano, Yasuhiko Kobayashi, Nobuhiko Ito.   

Abstract

An analysis of ionizing radiation-induced damage in peripheral lymphocytes has been employed to predict the prognosis of radiotherapy in terms of toxicity in normal tissues. Therefore, understanding the sensitivity of lymphocytes to high linear energy transfer (LET)-charged particles would be indispensable for utilizing charged particle therapy in veterinary medicine. However, the availability of such information is very limited. This study aimed to compare the radiosensitivity of feline T lymphocytes to gamma-rays (0.2 keV/microm) and 4 different types of charged particles with LET values ranging from 2.8 to 114 keV/microm. It was observed that the relative biological effectiveness, inactivation cross-section, and isodose-induced apoptosis increased in an LET-dependent manner. On the other hand, no difference in apoptosis frequency was observed in the cells exposed to an isosurvival dose of all the radiation types tested. This is the first study that demonstrates the LET dependence of cell killing and apoptosis induction in feline T lymphocytes. Our results suggest that lymphocytes can be effectively used to predict the prognosis of charged-particle therapy in cat patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611356     DOI: 10.1292/jvms.69.605

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  1 in total

1.  Annexin V FITC conjugated as a radiation toxicity indicator in lymphocytes following radiation overexposure in radiotherapy programs.

Authors:  Mohammad Bagher Tavakoli; Majid Kheirollahi; Ali Kiani; Mohammad Kazemi; Shaghayegh Haghjooy Javanmard; Leili Mohebat
Journal:  Adv Biomed Res       Date:  2015-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.